S
SEELOS THERAPEUTICS, INC.
NASDAQ: SEELQ (Seelos Therapeutics, Inc.)
Last update: 4 hours ago0.000
0.00 (0.00%)
| Avg. Volume (3M) | 1,826 |
| Market Cap | 58 |
| Price / Earnings (TTM) | 0.000 |
| Price / Sales | 421.90 |
| 52 Weeks Range | |
| Earnings Date | 12 Aug 2025 - 18 Aug 2025 |
| Profit Margin | 203.13% |
| Operating Margin (TTM) | -834.84% |
| Diluted EPS (TTM) | 0.980 |
| Quarterly Revenue Growth (YOY) | 11.90% |
| Current Ratio (MRQ) | 0.080 |
| Operating Cash Flow (TTM) | -13.27 M |
| Levered Free Cash Flow (TTM) | -34.28 M |
| Return on Assets (TTM) | -261.11% |
AIStockmoo Score
-0.5
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 0.0 |
| Average | -0.50 |
| % Held by Insiders | 11.15% |
| % Held by Institutions | 9.28% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Flagship Wealth Advisors, Llc | 30 Sep 2025 | 0 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |